WBBA Announces Stacie D. Byars as Director of Marketing and Membership

SEATTLE--(Business Wire)--
The Washington Biotechnology & Biomedical Association (WBBA), the Pacific
Northwest`s leading life sciences association, announced today that Stacie D.
Byars has joined the organization as Director, Marketing and Membership.

"Stacie adds more than 20 years of experience in biotechnology, medical device
and high-tech marketing, corporate communications and investor relations to the
WBBA team," said WBBA President Chris E. Rivera. "Her insight and expertise will
be instrumental as we focus on delivering intrinsic value to our more than 450
members and continue in our mission to support the growth of the life sciences
industry in the Pacific Northwest."

As Director of Marketing and Membership, Byars will develop and direct WBBA`s
messaging and communications strategies to promote positive image, optimize
media opportunities and cultivate strategic relationships, as well as build a
comprehensive marketing program for membership development, recruitment and
retention.

"I`m thrilled to join the WBBA team at this pivotal time and to have the
opportunity to impact the industry in a broad and meaningful way," said Byars.
"I look forward to leveraging my industry experience and regional relationships
in the hope of delivering results in a highly efficient and effective way and to
work in close, long-term partnerships with our members."

Prior to joining WBBA, Byars established SDByars Communications, LLC, an
independent agency focused on the development, implementation and evaluation of
communications strategies. Since 2006, she provided strategic consulting
services for public, private and non-profit organizations including: BiPar
Pharmaceuticals, Orexigen Therapeutics, Elan Pharmaceuticals, McKesson
Specialty, Targeted Genetics Corporation, Celladon Corporation, Calistoga
Pharmaceuticals, and Northwest Association for Biomedical Research, BioCentury
Publications, Argenta Reimbursement Advisors, University of Washington
Biotechnology and the Biomedical Technology Institute. She also held corporate
communications and investor relations positions for Targeted Genetics
Corporation, Nastech Pharmaceuticals, NeoRx (now Poniard) and NeoPath (now
TriPath Imaging).

Ms. Byars received her B.S. in Business Administration from the University of
Washington Bothell. She also served in the United States Navy in both domestic
and international training commands.

About the WBBA

The Washington Biotechnology & Biomedical Association is a not-for-profit
association of more than 450 life sciences companies, universities, academic
institutions and others working together with the mission of providing better
health to people everywhere. Since 1990, the WBBA has been headquartered in
Seattle and has had a staff member in Eastern Washington for more than two years
working to help the industry translate innovation to commercialization and the
creation of more life science jobs in the state. Members enjoy access to many
great events throughout the year, purchasing discounts, governmental advocacy,
timely industry news, as well as the opportunity to tap into the heart of the
life sciences community in Washington. For more information, visit WBBA online
at www.washbio.org or call 206-732-6700.

Washington Biotechnology & Biomedical Association
Stacie D. Byars, 206-732-6705

Copyright Business Wire 2009